healthcarenewsblogs

  Menopause causes uncomfortable symptoms, such as hot flashes, vaginal dryness, and weight gain and menopause treatments such as hormonal and non-hormonal treatments help to relieve these symptoms. Over the years, major market players in the menopause treatment are focusing on various growth strategies such as product launches, product advancements and expansions to cater to the growing needs for patients seeking treatment for menopause symptoms. Global Menopause Treatment Market is expected to have a market value of USD 15,456.3 Million by 2027. For instance, in April 2019, Otsuka Pharmaceutical launched EQUELLE, a non-prescription, non-hormonal supplement to alleviate the frequency of hot flashes and muscle aches associated with menopause in the US. Such strategies push the demand for branded as well as generic menopausal drugs, thus promising huge growth for the industry. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/4579 Segment Anal...

  A particle counter is a tool for monitoring indoor air quality to understand the concentration of particles in the air in cleanrooms and workplaces. This device would not identify specifically what kinds of dust particulates are present in the air, but it will identify how many airborne particles of a certain size are present in the environment. According to MRFR analysis, the global particle counter market is expected to register a CAGR of ~7.1% during the forecast period of 2019 to 2025 and was valued at USD 89.23 million in 2018.The growth of the global particle counter market is determined by numerous factors such as increasing incidence of chronic disorders, stringent regulatory scenario, and the adoption of particle counters to maintain air quality. However, the high cost of particle counters and technical limitations of particle counters is projected to restrain the growth of the market during the forecast period. The global particle counter market is currently domina...

  Lymphatic obstruction or lymphedema is a long-term condition where the excess fluid forms in the body tissue and causes swelling commonly called edema. It develops due to the damaged lymphatic system. Sometimes it also develops after the treatment of breast cancer. According to MRFR analysis, the global lymphedema diagnostics market is expected to register a CAGR of ~7.1% during the forecast period of 2019 to 2025 and was valued at USD 22.6 million in 2018.The growth of the global lymphedema diagnostics market is determined by numerous factors such as increasing incidence of cancer, high prevalence of lymphedema, and the adoption of new diagnostic modalities. However, the short half-life of radiopharmaceuticals and the high cost of diagnostic tests is projected to restrain the growth of the market during the forecast period. The global lymphedema diagnostics market is currently dominated by several market players. The key players are involved in expansion, acquisition, and s...

  Global Asthma and COPD Drugs Market are expected to register a CAGR of 7.90% during the forecast period with a market value of USD 43,444.72 Million till 2025. Asthma is a type of inflammatory disease that affects the lungs and makes breathing difficult. It is one of the common chronic condition affecting many people across the globe. COPD or chronic obstructive pulmonary disease is an umbrella term used for a group of respiratory diseases such as emphysema and chronic bronchitis. Segment Analysis The Global Asthma and COPD Drugs Market have been segmented by disease, product, route of administration, and distribution channel. The market, based on disease, has been bifurcated into asthma and COPD. Based on product, asthma and COPD drugs market has been segregated into long-term asthma control medications and quick-relief medications. The long-term asthma control medications are further segmented into combination drugs, anticholinergics, inhaled corticosteroids, long-acting...

  As per digital 3D printing market analysts, the global market is anticipated to witness growth owing to the factors such as increasing applications of digital 3d printing in the healthcare industry as well as 3D Printing techniques empowering medical practitioners. However, the digital 3D printing market will face challenges and restraints due to complex commercialization and lack of awareness during the forecast period 2018 to 2025. The global digital 3D printing market will grow at a CAGR of 20.54% during the forecast period 2018 to 2025. The market for digital 3D printing is set to reach US$5,214.8 million by 2025. The increasing application areas in dental & orthodontic treatments and orthopedic implants in the digital 3D printing market will support the growth. As per digital 3D printing market analysts, the digital 3D printing market based companies will face certain challenges during the forecast period 2018 to 2025. The digital 3D printing market research report pr...

  Acute pancreatitis is a condition where the pancreas becomes inflamed. The most common cause of acute pancreatitis is stones in the gallbladder. Acute pancreatitis is the single-most frequent gastrointestinal cause for hospital admissions in the US, with nearly 275,000 hospitalizations annually. Acute Pancreatitis Market is estimated to be valued at USD 7372.01 Million by 2025 and is expected to register a CAGR of 5.91% during the forecast period.There are several other reasons, such as heavy alcohol consumption, ingested medicines, and others that cause acute pancreatitis. The rising prevalence of gallstones and high consumption of alcohol is driving the global acute pancreatitis market. However, stringent regulations imposed by the FDA (Food and Drug Administration) are expected to hamper the growth of this market. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1565 Segment Analysis The Global Acute Pancreatitis Market has been segme...

  As per the new report furnished by Market Research Future (MRFR), the global life science and analytical instruments market , in 2016, was worth the value of USD 36.5 billion and will be attaining the valuation of USD 56.7 billion by the end of 2023. Furthermore, the market will be soaring high at a CAGR of 6.5 % during the forecast period (2017-2023). Key Vendors The key vendors competing in the global life science and analytical instrumentation market are Avance Biosciences (US), Becton, Thermo Fisher Scientific, Inc. (U.S.),   Agilent Technologies, Inc. (U.S.), Dickinson and Company (U.S.), Danaher Corporation (U.S), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer, Inc. (U.S.), Waters Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Charles River Laboratories International, Inc. (U.S.), Bruker Corporation (U.S.), Paragon Bioservices, Inc (US), Dynalabs (US) Shimadzu Corporation (Japan), Avista Pharma Solutions(US), Merck KGaA (Germany) among others. Reque...